Health Canada13 Jul 2026
Apo-Tiotropium Capsules; Out-of-specification (particle size)
Health Canada published a recall notice for Apo-Tiotropium Capsules; Out-of-specification (particle size) on 13 Jul 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 13 Jul 2026
- Recall type
- Health product recall
- Companies
- Apotex Inc. 150 Signet Drive Toronto ON, M9L 1T9
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The particle size did not meet the specifications in the affected lots. What you should do What to do: Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Apotex Inc. Apo-Tiotropium capsule DIN 02550865 Capsule Tiotropium bromide monohydrate 18 mcg LC87540 LC87541 LC87616 LC88196 LC88197 LC88316 LC88318 LC88319 LC89638 LC89639 LC89640 LC89641 LC89671 LC89681 LC89725 LC89783 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.